On December 3rd, 2013, swissnex Boston had the pleasure to welcome Solvias and Rohner Chem, two pharmaceutical companies headquartered in the greater Basel region, Switzerland. Solvias is a CRO developing flexible, customized solutions that meet specific drug-development needs. Solvias works closely with its partner Rohner Chem, which offers complementary manufacturing solutions for complex molecules.  James Schwindeman, Executive Vice President of RohnerChem North America, and Ronald Yarger, Vice President of Solvias North America, presented their companies and respective services to a targeted crowd of around 45 researchers and life Science experts.

To learn more about Solvias and Rohner Chemicals and their technology please follow them on:

-       Solvias: http://www.solvias.com/